Skip to content

Time Lapse Assisted Embryo Selection Versus Non Invasive PGT-A Assisted Embryo Selection

IVF Outcomes Based on Time Lapse Assisted Embryo Selection Versus Non Invasive PGT-A Assisted Embryo Selection

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05545995
Enrollment
200
Registered
2022-09-19
Start date
2022-10-31
Completion date
2024-03-31
Last updated
2022-09-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aneuploidy, Chromosome Abnormality, Infertility

Keywords

IVF, PGT-A, NON- INVASIVE PGT-A, TIME LAPSE, EMBRYO SELECTION

Brief summary

This is a prospective randomised study of the evaluation of the clinical IVF results after time lapse assisted embryo selection versus Non-invasive PGT-A assisted embryo selection in subfertile women.

Detailed description

A randomized prospective study focusing on subfertile women undergoing IVF treatment followed by embryo transfer on the blastocyst stage. Women assigned to group A proceed to embryo transfer, after time lapse assisted embryo selection, while women of group B after non-invasive PGT-A assisted embryo selection. IVF outcomes, regarding the success rate of the trasnfer and the time required to achieve conception is studied in both groups.

Interventions

The basis of embryo seletion for transfer: morphological or genetic after non-invasive PGT-A

Sponsors

Assisting Nature
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 39 Years
Healthy volunteers
Yes

Inclusion criteria

* Women who followed IVF treatment * 39 years old or younger * Single embryo transfer * blastocyst stage cultured embryos

Exclusion criteria

* women over the age of 39 years * not blastocyst transfer (transfers performed at earlier embryo stage) * double embryotransfer * women who had invasive PGT-a test * women whose embryos were not time-lapse monitored

Design outcomes

Primary

MeasureTime frameDescription
Embryotransfers to conceiveUp to the embryotransfer of the last enrolled patient (Dec 2023)The number of the embryotransfers required for women to conceive
Time interval to conceiveUp to the pregnancy test after the last embryo transfer of an enrolled patient (Jan 2024)Time interval required for women to conceive (in months): from OPU day to positive hCG test
Cumulative Live Birth RateUp to 38 weeks after the embryo transferCumulative Live Birth Rate achieved after one OPU treatment

Secondary

MeasureTime frameDescription
Abortion rateUp to 2nd trimester miscarriagesThe spontaneous miscarriage of women in both groups
DaC rateUp to 24 weeks of pregnancy according to Greek LawThe rate of the dilation and curretage rate in both groups

Countries

Greece

Contacts

Primary ContactEvangelos Papanikolaou, MD,PhD
drvagpapanikolaou@yahoo.gr00302310424294
Backup ContactMaria Galiotou, MSc
galiotou@assistingnature.gr00302310424294

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026